...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia
【24h】

Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia

机译:加泰罗尼亚糖尿病人群中需要肾脏替代治疗的慢性肾脏疾病第5期的发病率演变

获取原文
获取原文并翻译 | 示例

摘要

Background Chronic kidney disease due to diabetes (DCKD) is the main known cause of renal replacement therapy (RRT) initiation. A Centers for Disease Control and Prevention study showed that the rate of DCKD cases initiating RRT among the overall DM population has dropped in the USA. Our main objective was to analyse this rate in Catalonia in 1994, 2002, 2006 and 2010. Cardiovascular risk factors (CVRF) in the diabetic population and characteristics and survival of DCKD patients on RRT were also evaluated. Methods Data from the Catalan Renal Registry was used to learn the number of DCKD cases on RRT together with their characteristics and survival rates. Data from the Catalonia Health Survey established the diabetic population and also the prevalence of CVRF in this population.ResultsThe adjusted rate (95% CI) of patients initiating RRT with DCKD was 509.1 (484.6-533.7) pmp in 1994, 645.3 (621.6-669.0) in 2002, 602.6 (581.4-623.9) in 2006 and 600.0 (578.4-621.6) in 2010. Survival of DCKD patients in the 4th year of RRT had increased progressively from 35.9% for DCKD cases versus 64.9% for CKD cases due to other causes in 1994, to 39.9% versus 58.3% in 2002 and to 59.9% versus 65.9% in 2006. Conclusions Since 2002, the rates of patients with DCKD initiating RRT among the overall DM population decreased slightly in Catalonia. Survival in these cases has increased progressively and in 2006 is similar to the CKD patients due to other causes. This figure suggests a better overall management, especially of CVRF.
机译:背景技术糖尿病引起的慢性肾脏疾病(DCKD)是引发肾脏替代治疗(RRT)的主要已知原因。疾病控制与预防中心的一项研究表明,在整个DM人群中,发起RRT的DCKD病例的比率在美国有所下降。我们的主要目标是分析1994、2002、2006和2010年加泰罗尼亚的这一比率。还评估了糖尿病人群的心血管危险因素(CVRF)以及接受RRT的DCKD患者的特征和生存率。方法使用加泰罗尼亚肾脏登记处的数据来了解RRT上DCKD病例的数量,特征和生存率。加泰罗尼亚健康调查的数据确定了糖尿病人群以及该人群中的CVRF患病率。结果1994年发起DCKD RRT的患者调整率为959.1(484.6-533.7)pmp,645.3(621.6-669.0)pmp )在2002年,2006年的602.6(581.4-623.9)和2010年的600.0(578.4-621.6)。RRT第4年DCKD患者的生存率从DCKD病例的35.9%逐渐增加到CKD病例的64.9%,这是由于其他原因原因在1994年,分别为39.9%和2002年的58.3%和2006年的59.9%和65.9%。结论2002年以来,加泰罗尼亚地区全部DM人群中DCKD引发RRT的患者比率略有下降。这些病例的存活率逐渐提高,由于其他原因,2006年的存活率与CKD患者相似。这个数字表明更好的整体管理,尤其是CVRF。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号